This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.2165/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80967322
rdf:type
wikibase:Item
schema:description
artikull shkencor i botuar më 01 janar 1998 scientific article published on 01 January 1998 wetenschappelijk artikel наукова стаття, опублікована в січні 1998 im Jahr 1998 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en xineru de 1998
p:P577
wds:Q80967322-EA6C94D3-4017-49EA-8E70-0B0FF3D22847
wdt:P577
1998-01-01T00:00:00Z
p:P2860
wds:Q80967322-E2BF47B8-BC8C-4D47-9304-41298FF36609 wds:Q80967322-FB304CBC-D05D-4C55-9F57-58C7A8A90EF2 wds:Q80967322-B681C7D5-A11C-45A2-A0FA-98AA4E7CB6D0 wds:Q80967322-BDEB099C-01F3-43B0-ADBE-E13716AA195E wds:Q80967322-C17AFE86-960E-40A2-B3A9-5B9F24B0784A wds:Q80967322-D353513D-CC05-4571-A291-6A7072293C85 wds:Q80967322-D554163B-6445-463D-80D2-553FFF07DDE9 wds:Q80967322-62D4E37B-F151-4449-947C-CD8393A8FF60 wds:Q80967322-6FC6576B-E00A-4CDD-95B5-B66D1C04A4B5 wds:Q80967322-7D639B98-0A8D-42FC-9CAB-45A2195230B1 wds:Q80967322-84867D46-71D0-43D3-871E-326378BF505F wds:Q80967322-926E6140-46E6-4750-BFF8-1FF627289A84 wds:Q80967322-9B911F99-2B5A-40EB-AEC7-CBCF7A1164D0 wds:Q80967322-34AA5AEC-7AC3-454F-B51E-C87CEEF4A6DF wds:Q80967322-42371544-1C0C-4407-9559-03E0340D758B wds:Q80967322-51013F37-0073-4E97-A733-4317946B51FA wds:Q80967322-5235A254-C124-44D1-9F57-9ED968720A32 wds:Q80967322-598DAC51-ACDF-4D57-8418-8C959FA433DD wds:Q80967322-5C81996A-3979-40AD-AE92-426632444D8B wds:Q80967322-1FB4A9F3-3143-4F94-9AC4-11259F785969 wds:Q80967322-202501F4-4784-4CEC-A84E-A82F7AA2DC71 wds:Q80967322-203661CA-9EF9-46FF-8610-F0B701C77827 wds:Q80967322-21DE2E07-E2EE-409C-8AA8-6BF4F5381E79 wds:Q80967322-33D3C934-2F18-485C-AC04-2B89F7A713FC wds:Q80967322-02EBBC0E-C052-47EB-AA98-611BF119C8D3 wds:Q80967322-0355A283-D844-4B5C-838E-8B725C719547 wds:Q80967322-0787132F-B6B5-40D3-9393-AEBBD98D0DFB wds:Q80967322-1B6B21CE-FB45-495E-827A-D394DE29A836
wdt:P2860
wd:Q72111147 wd:Q53724501 wd:Q38143864 wd:Q36761035 wd:Q67647462 wd:Q71752287 wd:Q54217230 wd:Q64912322 wd:Q72849010 wd:Q28335303 wd:Q53837272 wd:Q34682963 wd:Q57704416 wd:Q40370025 wd:Q70704481 wd:Q72081327 wd:Q39652278 wd:Q72752999 wd:Q54609403 wd:Q70174125 wd:Q71147429 wd:Q43622090 wd:Q53452950 wd:Q71087118 wd:Q71289732 wd:Q74462467 wd:Q70594857 wd:Q39520531
p:P2093
wds:Q80967322-2E3C92C7-8CEA-4E4C-8D2B-6EA50066B549 wds:Q80967322-EE408037-F0CE-45FB-AC93-400331BC7880 wds:Q80967322-B1933832-5C98-41E9-B74C-6AC2BFBF9D3A
wdt:P2093
R Faedda A Satta E Bartoli
rdfs:label
Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome
skos:prefLabel
Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome
schema:name
Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome
p:P50
wds:Q80967322-2A3F2CF4-AAA6-41FD-BA01-C8766931931A
wdt:P50
wd:Q53754880
p:P1476
wds:Q80967322-8BD226C4-C6CD-4980-9B35-BF32167A8453
wdt:P1476
Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome
p:P304
wds:Q80967322-A72C3665-FD62-4D50-80E5-094FA807D981
wdt:P304
211-218
p:P31
wds:Q80967322-A1C73CAA-F0C1-4A0B-A715-9C58104BEC72
wdt:P31
wd:Q13442814
p:P921
wds:Q80967322-E983A05F-7FEF-4847-A9F7-95C5E7290D08 wds:Q80967322-3E174483-1250-41AD-AB39-E8817C553A91
wdt:P921
wd:Q55787775 wd:Q504790
p:P698
wds:Q80967322-397F2303-1B8C-475B-9B01-CF844485854F
wdtn:P698
n12:18370542
wdt:P698
18370542
p:P1433
wds:Q80967322-F1F81F7A-6A5D-41F0-B517-65D79980A393
wdt:P1433
wd:Q15753215
p:P433
wds:Q80967322-1EC7CA11-EC7B-473A-A4E2-C1FD68BA098A
p:P478
wds:Q80967322-1AC0B609-5F92-4E15-A99D-91E3B1DB3A98
wdt:P433
3
wdt:P478
16
p:P356
wds:Q80967322-BA87ECD1-6646-4578-A8A8-05642EB0406D
wdtn:P356
n11:00044011-199816030-00005
wdt:P356
10.2165/00044011-199816030-00005